About Saint Genevieves Place at
Services
Type of Care
Substance use treatment; Transitional housing, halfway house, or sober home; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment
Hospitals
Psychiatric hospital
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Relapse prevention; Substance use disorder counseling; 12-step facilitation
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; The Joint Commission
Payment/Insurance/Funding Accepted
IHS/Tribal/Urban (ITU) funds; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Adult women; Adult men; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Discharge Planning; Naloxone and overdose education
Recovery Support Services
Self-help groups
Education and Counseling Services
Substance use disorder education; Group counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Other languages (excluding Spanish)
Other Languages
French
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Mental health services; Transportation assistance; Suicide prevention services
Type of Care
Substance use treatment; Transitional housing, halfway house, or sober home; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment
Hospitals
Psychiatric hospital
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies
Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Contingency management/motivational incentives; Motivational interviewing; Relapse prevention; Substance use disorder counseling; 12-step facilitation
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State department of health; The Joint Commission
Payment/Insurance/Funding Accepted
IHS/Tribal/Urban (ITU) funds; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid
Special Programs/Groups Offered
Adult women; Adult men; Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Breathalyzer or blood alcohol testing; Drug or alcohol urine screening
Transitional Services
Discharge Planning; Naloxone and overdose education
Recovery Support Services
Self-help groups
Education and Counseling Services
Substance use disorder education; Group counseling
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Other languages (excluding Spanish)
Other Languages
French
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Mental health services; Transportation assistance; Suicide prevention services
